should i do glp 1 GLP-1 receptor agonists GLP-1 medications for weight loss

Chem Phys Lipids 235:105027

A 2025 study of 141 people with BED found that 70.2 percent of people treated with a combination of therapy and Vyvanse went into remission, making it almost twice as effective as medication or therapy alone

Limited, well-timed use around surgical repair, embryo transfer, or ovulation could still exploit the pro-repair and angiogenic effects while minimizing systemic exposure

Opioid use may worsen gastric retention Higher prevalence of recent opioid use in the high RGC group Suggests an additive effect on gastric motility No difference in indication or duration of therapy Whether patients used GLP-1 RAs for diabetes or weight loss did not affect risk Duration of therapy was not a significant predictor Interpretation Withholding 7.5 days higher risk of retained gastric contents Fasting 21.3 hours strongest predictor of high RGC These thresholds optimize sensitivity and specificity for detecting risk

The then 16-year-old told her he wanted to try the treatment that had helped her

Approach to the adult with acute diarrhea in resource-limited countries